drugset / Trial / NCT01181986

The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes

NCT01181986

RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of this investigation is to evaluate whether exenatide, a type 2 diabetes medication, will improve the function of the innermost part of the arterial wall called the endothelium after a fat-enriched meal and to determine how this occurs. The results of this study will help to determine and understand a novel action of this group of diabetes medications based on the action of naturally occuring gut substances called incretins. This may have a significant impact on cardiovascular health in patients with early and longstanding diabetes.

Timeline

Start
2010-08
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Avexitide Peptide 600 unknown Intravenous
Subject Exenatide Peptide 50 ng Subcutaneous
Subject Exenatide Peptide 5 ug Subcutaneous
Subject Exenatide Peptide 10 ug Subcutaneous